COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year

COVID-19 is associated with a high incidence of thrombotic complications, which can be explained by the complex and unique interplay between coronaviruses and endothelial cells, the local and systemic inflammatory response, and the coagulation system. Empirically, an intensified dose of thrombosis p...

Descripción completa

Detalles Bibliográficos
Autores principales: Leentjens, Jenneke, van Haaps, Thijs F, Wessels, Pieter F, Schutgens, Roger E G, Middeldorp, Saskia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078884/
https://www.ncbi.nlm.nih.gov/pubmed/33930350
http://dx.doi.org/10.1016/S2352-3026(21)00105-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078884/
https://www.ncbi.nlm.nih.gov/pubmed/33930350
http://dx.doi.org/10.1016/S2352-3026(21)00105-8

Ejemplares similares